ESSA Pharma News

ESSA Pharma | 8-K: Current report

24minutes ago

ESSA Pharma | 8-K: Current report

Dec 6 07:04 ET

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(0.0%),Biotech Growth N.V. N/A(0.0%)

Nov 14 19:37 ET

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PFM Health Sciences, LP(6.2%),PFM Health Sciences GP, LLC(6.2%), etc.

Nov 14 17:23 ET

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(7.4%),Roderick Wong, M.D.(7.4%)

Nov 14 07:02 ET

ESSA Pharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL MANAGEMENT, LLC(9.7%),KEVIN TANG(9.7%), etc.

Nov 8 17:00 ET

ESSA Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BML Investment Partners, L.P.(9.4%)

Nov 7 12:54 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner BIOTECH GROWTH N V

Nov 5 12:11 ET

ESSA Pharma | 8-K: Current report

Nov 1 16:33 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

Oct 7 15:03 ET

ESSA Pharma | 8-K: Current report

Sep 16 14:08 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

Sep 9 14:05 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

Sep 3 19:02 ET

ESSA Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 3 16:23 ET

ESSA Pharma | 8-K: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024

Aug 5 07:08 ET

ESSA Pharma | 10-Q: Q3 2024 Earnings Report

Aug 5 07:03 ET

ESSA Pharma | 8-K: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024

May 14 07:04 ET

ESSA Pharma | 10-Q: Q2 2024 Earnings Report

May 14 07:04 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

May 6 17:21 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Glickman Richard M

Apr 25 10:40 ET